Infections in Pediatric Cancer Patients

NCT00930267 | Unknown

• 1 other identifier: yael12-HMO-CTIL
• Study Type: observational
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

A prospective epidemiological study conducted in pediatric hematology oncology center in Hadassah medical center. The study will include all newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during chemotherapy. In each event of febrile episode during chemotherapy, the following data will be collected using a patient data form and computerized software. Demographic data: age, gender, ethnicity. Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event. Imaging data Microbiological data Outcome The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.

Conditions

Infections

Keywords

fever; children; cancer; leukemia; stem cell transplantation; infections in pediatric cancer patients presenting with fever during or following chemotherapy.

Eligibility Criteria

• Age: Up to 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

All newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

You may qualify if:

• Pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Sponsors & Collaborators

• Hadassah Medical Organization: lead

MeSH Terms

Conditions

Infections; Fever; Neoplasms; Leukemia

Condition Hierarchy (Ancestors)

Body Temperature Changes; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Neoplasms by Histologic Type; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Officials

• Dan Engelhard, MD

  Hadassah Medical Organization

  PRINCIPAL INVESTIGATOR

• Diana Averbuch, MD

  Hadassah Medical Organization

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Arik Tzukert, DMD

CONTACT

00 972 2 6776095; arik@hadassah.org.il

Hadas Lemberg, PhD

CONTACT

00 972 2 6777572; lhadas@hadassah.org.il

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: June 28, 2009
• First Posted: June 30, 2009
• Last Updated: June 30, 2009

Record last verified: 2009-06